FDA Approved: GUANFACINE — Supplemental Application (Actavis Pharma, Inc.)

View source ↗

Summary

The FDA approved Actavis Pharma, Inc.'s supplemental application for guanfacine, enabling the generic product to enter the market.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Attention Deficit Hyperactivity Disorder
• Hypertension

Drugs mentioned

• Guanfacine (guanfacine)

Snippet

SUPPL AP for GUANFACINE (GUANFACINE)